Brian Ritchie
LifeSci Advisors
Replay available
Soleno Therapeutics, Inc. (SLNO) Q1 2025 Earnings Call
Soleno Therapeutics, Inc. (NASDAQ: SLNO) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Anish Bhatnagar
Chairman and Chief Executive Officer, Celeno Therapeutics
Meredith Manning
Chief Commercial Officer, Celeno Therapeutics
Jim McInnis
Chief Financial Officer, Celeno Therapeutics
Yasmin Rahimi
Analyst, Piper Sandler
Devjit Chattopadhyay
Analyst, Guggenheim Securities
Kristin Kluska
Analyst, Kantor
Leland Gershaw
Analyst, Oppenheimer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Soleno Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:06.410 -- 00:00:08.410 Thank 00:00:35.915 -- 00:00:37.915 you. 00:00:48.530 -- 00:00:50.530 Greetings 00:00:55.839 -- 00:01:00.965 and welcome to the Celeno Therapeutics first quarter 2025 earnings 00:01:00.965 -- 00:01:07.431 conference call. At this time, note that all participants are in a listen-only mode. 00:01:07.433 -- 00:01:13.321 Should you require operator assistance, please press star zero on your telephone keypad. 00:01:13.321 -- 00:01:17.318 A question and answer session will follow the formal presentation. 00:01:17.318 -- 00:01:22.425 You may press star 1 at any time to be placed into the question queue, 00:01:22.425 -- 00:01:28.492 and we ask that you please ask one question and one follow-up, then return to the queue. 00:01:28.492 -- 00:01:31.737 As a reminder, this conference is being recorded. 00:01:31.737 -- 00:01:36.162 It is now my pleasure to turn the call over to Brian Ritchie of LifeSci Advisors. 00:01:36.162 -- 00:01:38.683 Please go ahead, Brian. 00:01:39.266 -- 00:01:44.453 Thank you, Operator. Good afternoon, everyone, and thank you for joining us to discuss 00:01:44.453 -- 00:01:49.156 Salino Therapeutics' first quarter 2025 financial 00:01:49.156 -- 00:01:54.384 and operating results. Please note, we'll be making certain forward-looking statements 00:01:54.384 -- 00:01:59.512 today. We refer you to Celeno's SEC filings for a discussion 00:01:59.512 -- 00:02:05.962 of the risks that may cause actual results to differ from the forward-looking statements. 00:02:05.962 -- 00:02:10.970 On the call with me today from Celeno are Anish Bhatnagar, Celeno's Chairman and Chief 00:02:10.970 -- 00:02:16.567 Executive Officer, Meredith Manning, Celeno's Chief Commercial Officer, 00:02:16.567 -- 00:02:20.373 and Jim McInnis, Spilano's Chie...